Results for: teva+pharmaceutical+industries

Teva offers to buy Mylan in $40.1B cash-and-stock deal

Top Mylan shareholders seek deal with Teva - sources

Teva's turnaround CEO sets sights on $40 billion mega-deal

Generic drugmaker Teva makes $40 billion offer for rival Mylan

Wall Street's two major indexes drop oil falls

Ahead of the Bell: Biogen shares keep climbing

FDA accepts application for new Sanofi MS drug

Pharmaceutical giant Teva announces departure of CEO

Exclusive: Mylan near multibillion-dollar deal for Abbott drug assets -...

Ranbaxy, Teva settle New York antitrust drug claims

In quest for next windfall, tech funds look to healthcare

U.S. justices uphold firms' religious objections to contraception

AstraZeneca loses German court appeal over Seroquel XR drug patent

Exclusive: Express Scripts presses for more drug savings with coverage list

Pfizer $33 Billion Question Remains After Teva, Actavis Feelers

$2.25M penalty for Missouri pharmaceuticals plant

Israeli drug maker in uproar over planned layoffs